BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2009
View Archived Issues
Tufts College presents new proteasome inhibitors potentially useful for treatment of cancer
Read More
IntraCellular Therapies describes new norepirephrine/serotonin transporter inhibitors
Read More
GlaxoSmithKline assesses safety and reactogenicity of HIV vaccine 732461
Read More
Emergent BioSolutions evaluates safety and pharmacokinetics of anthrax immune globulin
Read More
First human study of TUTI-16 in HIV-infected subjects initiated by Thymon, LLC
Read More
Novel orally active quinoline derivative potently and selectively inhibits CETP
Read More
Cancer vaccine vectors based on adenoviruses from chimpanzees overcome immunity in vivo
Read More
New GPR119 receptor agonists for treating diabetes reported in recent Bristol-Myers Squibb patent
Read More
Roche imparts novel antidiabetic 11beta-HSD1 inhibitors
Read More
Amgen discloses novel CaSR ligands for treating hyperparathyroidism and other conditions
Read More
Chemokine CXCR4 receptor antagonists under development at Pharis Biotec
Read More
Epigenomics and Quest sign nonexclusive licensing agreement for mGSTP1 DNA biomarker
Read More
Novel protein kinase B inhibitors and their use in cancer therapy reported by Amgen
Read More
DeveloGen reports positive phase I results for DG-3173
Read More
Toray begins clinical trial of PEG-interferon beta in Japan
Read More
ImmunoVaccine signs agreement with NIH for its DepoVax vaccine enhancement system
Read More
ExonHit reports advances in the clinical development of EHT-0202 for AD
Read More
Final results presented for PROPEL pralatrexate trial in T-cell lymphoma
Read More
Neuroprotection seen with MP-124 in models of ischemia
Read More
NIH awards phase I grant to Oligomerix for biomarker assays in AD
Read More
Abbott successfully completes tender offer for Advanced Medical Optics
Read More
FDA approves Genzyme's Synvisc-One single injection OA treatment
Read More
Eisai and Teikoku Seiyaku sign option and license agreement for donepezil
Read More
EMEA halts European Commission decision process on Basilea's Zevtera
Read More
The Medicines Company completes tender offer for shares of Targanta
Read More